Literature DB >> 31802249

Preeclampsia as a risk factor for postpartum depression and psychosis: a systematic review and meta-analysis.

Luisa Caropreso1,2, Taiane de Azevedo Cardoso3,4, Maha Eltayebani3,5, Benicio N Frey3,4.   

Abstract

Postpartum depression (PPD) and postpartum psychosis (PPP) are serious mental conditions that are usually not diagnosed early enough, leading to delayed treatment. Several studies confirmed an association between preeclampsia (PE) and psychiatric disorders during pregnancy. We conducted a systematic review of the literature aiming to investigate whether women with a history of PE are more likely to develop PPD or PPP, and whether PE is a risk factor for depression outside the perinatal period (PROSPERO protocol number CRD42018114188). We also conducted a meta-analysis to quantitatively assess the severity of depressive symptoms between women with and without a history of PE. A literature search with no year and no language restriction was conducted. The search yielded 950 articles, with 698 remaining after duplicate removal, and 13 being suitable for the systematic review. Eight of the 13 studies found an association between preeclampsia and depression. All studies assessed the impact of PE on depression, and only two studies assessed the impact of PE on PPP. Eight of the studies were included in the meta-analysis, which yielded a higher severity of depressive symptoms postpartum in women with PE. However, these results must be interpreted with caution considering the high heterogeneity of the included studies. Our meta-analysis also showed that women with a history of PE showed higher severity of depressive symptoms outside of the puerperal period. In conclusion, this systematic review and meta-analysis suggest that that PE is not only a risk factor for development of depression, but it is also associated with higher severity of depressive symptoms.

Entities:  

Keywords:  Depression; Postpartum psychosis; Preeclampsia; Pregnancy; Systematic review

Year:  2019        PMID: 31802249     DOI: 10.1007/s00737-019-01010-1

Source DB:  PubMed          Journal:  Arch Womens Ment Health        ISSN: 1434-1816            Impact factor:   3.633


  8 in total

1.  Preeclampsia and the longitudinal risk of hospitalization for depression at 28 years.

Authors:  Nathalie Auger; Nancy Low; Gilles Paradis; Aimina Ayoub; William D Fraser
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2020-07-11       Impact factor: 4.328

Review 2.  Role of ROS/RNS in Preeclampsia: Are Connexins the Missing Piece?

Authors:  María F Rozas-Villanueva; Paola Casanello; Mauricio A Retamal
Journal:  Int J Mol Sci       Date:  2020-06-30       Impact factor: 5.923

Review 3.  Phenomenology, Epidemiology and Aetiology of Postpartum Psychosis: A Review.

Authors:  Amy Perry; Katherine Gordon-Smith; Lisa Jones; Ian Jones
Journal:  Brain Sci       Date:  2021-01-04

4.  Risk factors of perinatal depression in women: a systematic review and meta-analysis.

Authors:  Kai Yang; Jing Wu; Xiangdong Chen
Journal:  BMC Psychiatry       Date:  2022-01-27       Impact factor: 3.630

5.  Predictors of Postpartum Depression among Italian Women: A Longitudinal Study.

Authors:  Sara Molgora; Emanuela Saita; Maurizio Barbieri Carones; Enrico Ferrazzi; Federica Facchin
Journal:  Int J Environ Res Public Health       Date:  2022-01-29       Impact factor: 3.390

6.  The Effect of Selenium Supplementation on Clinical Outcomes, Metabolic Profiles, and Pulsatility Index of the Uterine Artery in High-Risk Mothers in Terms of Preeclampsia Screening with Quadruple Test: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial : Selenium and preeclampsia.

Authors:  Elahe Mesdaghinia; Farah Shahin; Amir Ghaderi; Daryoush Shahin; Mohammad Shariat; Hamidreza Banafshe
Journal:  Biol Trace Elem Res       Date:  2022-02-28       Impact factor: 3.738

7.  Cardiovascular Health After Preeclampsia: Patient and Provider Perspective.

Authors:  Ellen W Seely; Ann C Celi; Jaimie Chausmer; Cornelia Graves; Sarah Kilpatrick; Jacinda M Nicklas; Mary L Rosser; Kathryn M Rexrode; Jennifer J Stuart; Eleni Tsigas; Jennifer Voelker; Carolyn Zelop; Janet W Rich-Edwards
Journal:  J Womens Health (Larchmt)       Date:  2020-09-28       Impact factor: 2.681

Review 8.  A new molecular risk pathway for postpartum mood disorders: clues from steroid sulfatase-deficient individuals.

Authors:  Harish Thippeswamy; William Davies
Journal:  Arch Womens Ment Health       Date:  2020-11-20       Impact factor: 3.633

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.